Effect of Qigong Therapy in Patients With Advanced Lung and Gastrointestinal Cancer Undergoing Ch… (NCT01374100) | Clinical Trial Compass
TerminatedNot Applicable
Effect of Qigong Therapy in Patients With Advanced Lung and Gastrointestinal Cancer Undergoing Chemotherapy
Stopped: Slow accrual, and revised power calculation for primary end-points
Canada52 participantsStarted 2009-02
Plain-language summary
Cancer patients face a number of symptoms related to treatment or disease which may impair quality of life, such as decreased functional capacity, fatigue, nausea an vomiting, distress, depression and unmet psychological needs. Due to this array of symptoms, cancer patients often seek supportive complementary and alternative medicine, which many patients use along with conventional treatments. Qigong, a type traditional chinese medicine, is a mind-body exercise that combines meditation, slow physical movements, and controlled breathing. The investigators hypothesise that Qigong therapy is better in the reduction of anxiety and depression levels and the improvement of quality of life in patients with lung and gastrointestinal (GI) cancer who are eligible for anti-cancer treatment, when compared to standard exercise training.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. A pathologically (histological or cytological) confirmed clinical diagnosis of non-small cell lung cancer (NSCLC) or GI cancer
✓. Stage 3 or 4 disease and eligible for anti-cancer treatment
✓. Performance status (PS) of 0 - 2 as determined by the Eastern Cooperative Oncology Group-Performance Status
✓. Life expectancy estimated at \> 4 months
✓. Age 18 years or older
✓. Willing and able to provide informed consent
✓. Must be approved for participation by the oncology treatment team
✓. Able to communicate in French or English
Exclusion criteria
✕. Contraindication to exercise as determined by the oncology treatment team
✕. Severe cardiac or neuro-muscular/skeletal disease